HLA-C and neoplasm: The most commonly used form of antigens, are pre-determined immunogenic peptide epitopes derived from TAA, which are restricted to specific MHC haplotypes; or whole tumor antigens, which are theoretically more advantageous than peptide antigens because they can be processed into epitopes that can be presented regardless of patients' MHC haplotypes.